HGH
Get informed when a big investor buys or sells
+ FollowApril 24, 2026 - AI Summary
Overvalued by 0% based on the discounted cash flow analysis.
| Market cap | $34.85 Billion |
|---|---|
| Enterprise Value | $39.06 Billion |
| Dividend Yield | $15.31 (1.76%) |
| Earnings per Share | $0.01 |
| Beta | 0.07 |
| Outstanding Shares | 278,300,000 |
| P/E Ratio | 8.71 |
|---|---|
| PEG | 24.28 |
| Price to Sales | 0.24 |
| Price to Book Ratio | 0.37 |
| Enterprise Value to Revenue | 1.36 |
| Enterprise Value to EBIT | 9.58 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.23 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data